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back at open symposia and conferences, was essential 
during the development of the Guidelines.
As one of the Integrated Research Projects for As-
sessing Medical Technology, sponsored by the Japanese 
Ministry of Health, Labour, and Welfare, a Research 
Group for the Preparation and Diffusion of Guidelines 
for the Management of Acute Biliary Tract Infection 
was established. With support from the Japanese Soci-
ety for Abdominal Emergency Medicine, the Japan 
Biliary Association, and the Japanese Society of Hepato-
Biliary-Pancreatic Surgery, development of the Guide-
lines for the Management of Acute Cholangitis and 
Cholecystitis has been underway since 2003.
After several open consensus conferences and open 
symposia to obtain feedback from members of these 
societies, a Japanese-language version of “Evidence-
Based Practice Guidelines for the Management of 
Acute Cholangitis and Cholecystitis” was prepared and 
published.
An English-language version of these Guidelines 
(draft) was discussed, via e-mail, with worldwide ex-
perts on acute cholangitis and cholecystitis, with the aim 
of publishing International Guidelines for the Manage-
ment of Acute Cholangitis and Cholecystitis. Much 
spirited debate, which changed many areas of diagnosis 
criteria, severity assessment, etc, then took place at the 
International Consensus Meeting, held in Tokyo on 
April 1 and 2, 2006, attended by experts from Japan and 
many other parts of the world. After several modiﬁ  ca-
tions by the Organizing Committee, the ﬁ  nal version is 
published here as the International Guidelines for the 
Management of Acute Cholangitis and Cholecystitis.
In this article, we outlined comments and opinions 
given at the International Consensus Meeting, 
Abstract
A systematic review of references conducted in the process of 
developing the Guidelines for the Management of Acute 
Cholangitis and Cholecystitis did not ﬁ  nd many high-quality 
research reports. There were no criteria for diagnosis, severity 
assessment, or patient transfer, and no established principles 
of clinical practice guidelines for acute cholangitis and chole-
cystitis. In order to develop guidelines that would be useful 
in clinical practice, an understanding of the current status of 
clinical practice for acute cholangitis and cholecystitis was 
considered essential. After several open symposia and a 
survey of these two diseases, we developed and published a 
Japanese-language version of Evidence-Based Practice Guide-
lines for the Management of Acute Cholangitis and Cholecys-
titis. In order to prepare international Guidelines, we had 
repeated discussions about the draft Guidelines together with 
international experts, and, following the Consensus Meeting, 
held on April 1–2, 2006, in Tokyo, with the attendance of 300 
world experts in the ﬁ  eld, the International Guidelines for the 
Management of Acute Cholangitis and Cholecystitis were de-
veloped. In this article, we outline the comments and opinions 
given at the International Meeting and how they are reﬂ  ected 
in the ﬁ  nal version of the Guidelines.
Key words  Guidelines · Consensus development meeting · 
Evidence-based medicine · Cholangitis · Acute cholecystitis
Introduction
Guidelines should not only be based on evidence but 
should also meet the needs of current medical practice. 
We thought that adequate discussion, to receive feed-
Offprint requests to: T. Mayumi
Received: May 31, 2006 / Accepted: August 6, 2006T. Mayumi et al.: Results of the Tokyo Consensus Meeting  115
and how they are reﬂ  ected in ﬁ  nal version of the 
Guidelines.
Changes made in the Guidelines at the International 
Consensus Meeting for the Management of Acute 
Cholangitis and Cholecystitis (Tokyo, April 1–2, 2006)
In order to prepare international guidelines based on 
the “Evidence-Based Practice Guidelines for the Man-
agement of Acute Cholangitis and Cholecystitis”, draft 
guidelines were modiﬁ  ed several times by the Organiz-
ing Committee, and discussion was carried out, via e-
mail, with worldwide experts on acute cholangitis and 
acute cholecystitis before the International Consensus 
Meeting.
The discussions were followed by the 2-day Interna-
tional Consensus Meeting, held in Tokyo on April 1–2, 
2006, with the attendance of about 300 world experts 
specializing in acute cholangitis and acute cholecystitis, 
in order to prepare evidence-based guidelines. Attend-
ees from abroad are listed (Page 8–10). Discussions at 
the Meeting are outlined below.
Diagnostic criteria for acute cholangitis
Some panelists proposed that “History of biliary dis-
ease” should be included in the diagnostic criteria for 
acute cholangitis (Table 1B). A history of biliary dis-
ease, such as gallstones, a history of previous biliary 
surgery, and having an indwelling biliary stent play an 
important role in making the diagnosis, as agreed upon 
by many participants at the Consensus Meeting. But 
other panelists disagreed and proposed different crite-
ria (Table 1C).
Because not only an increase but also a decrease in 
the WBC count indicates inﬂ  ammation, “leukocytosis” 
was changed to “abnormal WBC count”. Because C-
reactive protein (CRP) is sometimes not elevated, “or 
other evidence of inﬂ  ammatory response” was added. 
“WBC count” and “elevation of CRP level or other evi-
dence of inﬂ  ammatory response” are separate items.
As aspartate aminotransferase (AST) and alanine 
aminotransferase (ALT) sometimes increase in acute 
cholangitis, “abnormal liver function tests, alkaline 
phosphatase (ALP), γ-GTP, AST, ALT)” was added.
Imaging ﬁ  ndings of inﬂ  ammatory changes in acute 
cholangitis are also useful for diagnosis. “Biliary dilata-
tion or etiology (stricture, tumor, stones)” (Table 1A) 
was changed to “biliary dilatation, inﬂ  ammatory ﬁ  nd-
ings, or etiology (stricture, tumor, stones)” (Table 1B, 
C).
Two ways of making a deﬁ  nite diagnosis were 
proposed; in revision 1 (Table 1B), these were: (1) 
three or four items in A (Charcot’s triad) and (2) 
any item in A + two items in B + C, and in Revision 2 
(Table 1C), these were: Any item in A + two items in 
B + C.
As more than 90% of the participants at the Tokyo 
Consensus Meeting agreed on four criteria in revision 
1 (Table 1B), a history of biliary disease was included, 
and abnormal WBC count and elevation of CRP or 
other evidence of inﬂ  ammatory response were included 
in the ﬁ  nal version of the diagnostic criteria for acute 
cholangitis (Table 1D).
In Table 1D, two or more items in A were deﬁ  ned as 
a suspected diagnosis, and either: (1) Charcot’s triad 
(items 2 + 3 + 4 in A) or (2) two or more items in A plus 
both items in B + C, were deﬁ  ned as a deﬁ  nite diagnosis 
of acute cholangitis.
Severity assessment criteria for acute cholangitis 
(Table 2)
More than 70% of the participants at the Tokyo Con-
sensus Meeting agreed that the severity of acute chol-
angitis should be divided into three grades, severe (grade 
III), moderate (grade II), and mild (grade I). To stratify 
acute cholangitis into three grades, two different criteria 
were necessary, and it was decided to use “onset of 
organ dysfunction” and “response to the initial medical 
treatment” as criteria for the severity assessment of 
acute cholangitis.
“Severe (grade III)” acute cholangitis was deﬁ  ned as 
that associated with any one of the categories of organ/
system dysfunction or severe local inﬂ  ammation listed 
in Table 2. This was supported by more than 90% of the 
panelists at the International Consensus Meeting. But 
the thresholds of these categories were not discussed at 
the Summary session.
There was some argument about whether the score 
on an acute physiology scoring system, such as acute 
physiology and chronic health evaluation (APACHE) 
II, or a multiple organ dysfunction scoring system, such 
as Marshall’s system or the sepsis-related organ failure 
assessment (SOFA) system should be used as a criterion 
for severe (grade III) acute cholangitis. The principal 
advantage of these scoring systems is that they provide 
gradations of severity. The APACHE II system has 
been validated, especially for critical care patients, in-
cluding patients with sepsis, and acute cholangitis can 
be interpreted as a subset of sepsis. The disadvantage 
of these scoring systems is that the scores are some-
times troublesome to calculate, and critically speaking, 
they have not been satisfactory validated in patients 
with acute cholangitis. The vote on this argument 
showed that 37.8% of the panelists supported the use 
of APACHE II and 62.2% did not. As a result of this 
vote, the chairmen of this session, Drs. Yoshifumi 
Kawarada (Japan) and Henry Pitt (United States), 
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Table 1.  Diagnostic criteria for acute cholangitis
(A) Original
A.  Clinical signs  1.  Fever and/or chills
  2. Jaundice
  3.  Abd. pain (RUQ, epigastric)
B. Laboratory data  4.  Leukocytosis or elevation of CRP level
  5.  Elevation of ALP or γ-GTP level
C. Imaging ﬁ  ndings  6.  Biliary dilatation or etiology (stricture, tumor, stones)
----------------------------------------------------------------------------------------------------------------------------------------------------------------------
Deﬁ  nite diagnosis  (1)  All items in A (Charcot’s triad)
  (2)  One or two items in A + all items in B + C
Note: acute hepatitis and other causes of acute abdomen should be excluded
(B)  Proposed revision 1 at International Meeting
A.  Clinical context and manifestations  1.  History of biliary disease
  2.  Fever and/or chills
  3. Jaundice
  4.  Abd. pain (RUQ, epigastric)
B. Laboratory data  5.  Abnormal WBC count
  6.  Elevation of CRP level or other evidence of inﬂ  ammatory response
  7.  Abnormal liver function tests (ALP, γ-GTP, AST, ALT)
C. Imaging ﬁ  ndings  8.  Biliary dilatation, inﬂ  ammatory ﬁ  ndings, or etiology (stricture, tumor, stones)
----------------------------------------------------------------------------------------------------------------------------------------------------------------------
Deﬁ  nite diagnosis  (1)  Three or 4 items in A (Charcot’s triad)
  (2)  Any item in A + 2 items in B + C
Note: acute hepatitis and other causes of acute abdomen should be excluded
(C) Proposed revision 2 at International Meeting
A.  Clinical context and manifestations  1.  Fever and/or chills
  2. Jaundice
  3.  Abd. pain (RUQ, epigastric)
B. Laboratory data  4.  Abnormal WBC count
  5.  Elevation of CRP level or other evidence of inﬂ  ammatory response
  6.  Abnormal liver function tests (ALP, γ-GTP, AST, ALT)
C. Imaging ﬁ  ndings  7.  Biliary dilatation, inﬂ  ammatory ﬁ  ndings, or etiology (stricture, tumor, stones)
----------------------------------------------------------------------------------------------------------------------------------------------------------------------
Deﬁ  nite diagnosis  (1)  Any item in A + 2 items in B + C
Note: acute hepatitis and other causes of acute abdomen should be excluded
(D)  Final version of diagnostic criteria for acute cholangitis
A.  Clinical context and clinical  1.  History of biliary disease
    manifestations  2.  Fever and/or chills
  3. Jaundice
  4.  Abdominal pain (RUQ or upper abdominal)
B. Laboratory data  5.  Evidence of inﬂ  ammatory responsea
  6.  Abnormal liver function testsb
C. Imaging ﬁ  ndings  7.  Biliary dilatation, or evidence of an etiology (stricture, stone, stent, etc)
----------------------------------------------------------------------------------------------------------------------------------------------------------------------
Suspected diagnosis  Two or more items in A
Deﬁ  nite diagnosis  (1)  Charcot’s triad (2 + 3 + 4)
  (2)  Two or more items in A + both items in B + C
a Abnormal WBC count, increased serum CRP level, and other changes indicating inﬂ  ammation
b Increased serum ALP, γ-GTP (GGT), AST, and ALT levels
not APACHE II should be included as a criterion for 
severe (grade III) acute cholangitis to the Organizing 
Committee, and this proposal was approved by the 
audience.
Neither “recurrent symptom” nor “malignancy as eti-
ology” always shows moderate (grade II) acute cholan-
gitis. Therefore, both of these were deleted from the 
criteria for “moderate (grade II)” acute cholangitis. The 
thresholds of high fever and WBC counts were not 
decided.
After the International Meeting, all the criteria and 
thresholds of severity of acute cholangitis were dis-T. Mayumi et al.: Results of the Tokyo Consensus Meeting  117
Table 2.  Severity assess ment criteria for acute cholangitis
(A) Proposed severity assessment criteria at International Meeting
“Severe (grade III)” acute cholangitis
  “Severe (grade III)” acute cholangitis is that associated with dysfunctions of at least one of the following organs/systems
1. Cardiovascular  Hypotension
2.  Neurologic  Disturbance of consciousness
3. Respiratory  PaO2/FiO2 ratio <300, SpO2 decrease: (not decided)
4. Renal  Oliguria,  creatinine  >2.0 mg/dl
5. Hepatic  PT  > 15?, 20? Seconds? or INR > 1.5?, or PT prolongation?: (not decided)
6. Hematologic  Platelets  < 100 000/mm3?
7.  APACHE II?  To be included or not included? If yes, Score?
“Moderate (grade II)” acute cholangitis
  “Moderate (grade II)” acute cholangitis is that associated with at least one of the following factors
    High fever >39 °C?: (threshold level was not decided)
  WBC > 20 000/mm3? (threshold level was not decided)
    No remission for 48–72 h
    Recurrent symptom
    Malignancy as etiology
Note: elderly patients (>75 years) and patients with medical comorbidities should be closely monitored
“Mild (grade I)” acute cholangitis
“Mild (grade I)” acute cholangitis is that which does not meet the criteria for “severe” or “moderate” acute cholangitis. 
(i.e., neither organ dysfunction nor risk factors)
(B) Final version of severity assessment criteria for acute cholangitis
Mild (grade I) acute cholangitis
“Mild (grade I)” acute cholangitis is deﬁ  ned as acute cholangitis that responds to the initial medical treatmenta
Moderate (grade II) acute cholangitis
“Moderate (grade II)” acute cholangitis is deﬁ  ned as acute cholangitis that does not respond to the initial medical 
treatmenta and is not associated with organ dysfunction
Severe (grade III) acute cholangitis
“Severe (grade III)” acute cholangitis is deﬁ  ned as acute cholangitis that is associated with the onset of dysfunction at least 
in any one of the following organs/systems:
1. Cardiovascular system  Hypotension requiring dopamine 5 µg/kg per min, or any dose of dobutamine
2. Nervous system  Disturbance of  consciousness
3. Respiratory system  PaO2/FiO2 ratio <300
4. Kidney  Serum  creatinine  >2.0 mg/dl
5. Liver  PT-INR  > 1.5
6. Hematological system  Platelet count  <100 000/µl
Note: compromised patients, e.g., elderly (>75 years old) and patients with medical comorbidities, should be closely monitored
a General supportive care and antibiotics
cussed and decided or by the Organizing Committee 
(Table 2B). The deﬁ  nition of moderate (grade II) acute 
cholangitis was changed to: “acute cholangitis that does 
not respond to the initial medical treatment and is not 
associated with organ dysfunction (Table 2B).
Diagnostic criteria for acute cholecystitis (Table 3)
After the discussion during the Tokyo International 
Consensus Meeting, almost unanimous agreement was 
achieved (Table 3B). However, 19% of the panelists 
from abroad expressed the necessity for minor mo-
diﬁ  cations, because the diagnostic criteria did not in-
clude technetium hepatobiliary iminodiacetic acid 
(Tc-HIDA) scans as an item in the provisional version.
Some panelists insisted that “suspected diagnosis” 
was not necessary, and that only “deﬁ  nite diagnosis” 
should be included in the diagnostic criteria for acute 
cholecystitis. There was no discussion on whether, if 
“suspected diagnosis” was deleted, how the deﬁ  nition 
of deﬁ  nite diagnosis should be modiﬁ  ed.
After the International Meeting, “A. Local signs of 
inﬂ  ammation”; “B. Systemic signs of inﬂ  ammation” and 
“C. Imaging ﬁ  ndings” were clearly speciﬁ  ed in the diag-
nostic criteria for acute cholecystitis (Table 3B). Tc-
HIDA scan was included in “C. Imaging ﬁ  ndings”. 
“Suspected diagnosis” was deleted from the criteria.
Severity assessment criteria for acute cholecystitis 
(Table 4)
Before the International Meeting, “Severe (grade III)” 
acute cholecystitis was deﬁ  ned as that associated with 
dysfunction in any one of the organs/systems or any one 
of the severe local inﬂ  ammation categories listed in 
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Table 3.  Diagnostic criteria for acute cholecystitis
(A) Proposed at International Meeting
1.  (1) Murphy’s sign, (2) RUQ, mass/pain/tenderness, (3) rigidity/muscle guarding, (4) rebound tenderness
2.  (1) Fever, (2) abnormal WBC count, (3) elevated CRP
3. Imaging ﬁ  ndings characteristic of acute cholecystitis
----------------------------------------------------------------------------------------------------------------------------------------------------------------------
Suspected diagnosis: one item in 1.  and one item in 2.  are positive. (Suspected diagnosis may be deleted? If so, deﬁ  nition of 
deﬁ  nite diagnosis?)
Deﬁ  nite diagnosis: 3.  is positive in patients who fulﬁ  ll the criteria for suspected diagnosis
Note: acute hepatitis, other causes of acute abdomen, and chronic cholecystitis should be excluded
(B) Final version of diagnostic criteria for acute cholecystitis
A.  Local signs of inﬂ  ammation  (1) Murphy’s sign, (2) RUQ mass/pain/tenderness
B.  Systemic signs of inﬂ  ammation      (1) Fever, (2) elevated CRP, (3) elevated WBC count
C. Imaging ﬁ  ndingsa  Imaging ﬁ  ndings characteristic of acute cholecystitis
----------------------------------------------------------------------------------------------------------------------------------------------------------------------
Deﬁ  nite diagnosis
  (1) One item in A and one item in B are positive
  (2) C conﬁ  rms the diagnosis when acute cholecystitis is suspected clinically
Note: acute hepatitis, other acute abdominal disease, and chronic cholecystitis should be excluded
a Imaging ﬁ  ndings of acute cholecystitis
Ultrasonography
  •  Sonographic Murphy sign (tenderness elicited by pressing the gallbladder with the ultrasound probe)
  •  Thickened gallbladder wall (>4 mm, if the patient does not have chronic liver disease and/or ascites or right heart failure)
  •  Enlarged gallbladder (long axis diameter >8 cm, short axis diameter >4 cm)
  •  Incarcerated gallstone, debris echo, pericholecystic ﬂ  uid collection
  •  Sonolucent layer in the gallbladder wall, striated intramural lucencies, and Doppler signals
MRI
  •  Pericholecystic high signal
  • Enlarged  gallbladder
  •  Thickened gallbladder wall
CT
  •  Thickened gallbladder wall
  • Pericholecystic  ﬂ  uid collection
  • Enlarged  gallbladder
  •  Linear high-density areas in the pericholecystic fat tissue
Tc-HIDA scan (technetium hepatobiliary iminodiacetic acid scan)
  •  Non-visualized gallbladder with normal uptake and excretion of radioactivity
  •  Rim sign (augmentation of radioactivity around the gallbladder fossa) 
At the Meeting, concepts of the severity of acute 
cholecystitis were discussed and changed as shown 
below. The concept of the ﬁ  nal version of the severity 
assessment of acute cholecystitis, “severe (grade III)” 
acute cholecystitis was deﬁ  ned as that associated with 
organ dysfunction, “moderate (grade II)” acute chole-
cystitis was deﬁ  ned as that associated with difﬁ  culty to 
perform cholecystectomy due to local inﬂ  ammation, 
and “mild (grade I)” acute cholecystitis was deﬁ  ned as 
that which does not meet the criteria of “severe” or 
“moderate” acute cholecystitis.
In the severity assessment initially proposed at the 
Meeting “moderate (grade II)” acute cholecystitis was 
associated with any of the following conditions: (1) ab-
normal WBC (>15 000,  >18  000? threshold was not de-
cided), (2) palpable inﬂ  ammatory mass, (3) onset more 
than 72–96  h and (4) Serious wall thickening and ﬂ  uid 
collection around the gallbladder.
Some panelists insisted that “serious” should be 
changed to “thickening” or deleted. Whether threshold 
of wall thickening should be included was not discussed. 
If included, the extent of the thickness, whether 6–7 mm 
or 8  mm, or twice that of the normal gallbladder wall, 
also remained as questions. Also, it was queried wheth-
er both the thickness of the gallbladder wall and ﬂ  uid 
collection around the gallbladder were necessary for the 
diagnosis of moderate acute cholecystitis?
Panelists suggested that liver cirrhosis should be de-
scribed in a Note.
After the International Meeting, each item and its 
threshold were discussed and decided on by the Orga-
nizing Committee. “Severe local inﬂ  ammation” was 
deleted from the criteria for severe (grade III) acute 
cholecystitis (Table 4B). “Onset more than 72–96 h” was 
changed to “prolonged local signs of inﬂ  ammation” in 
the criteria for moderate (grade II) acute cholangitis.
Flowcharts
Flow charts for the management of acute cholangitis 
and acute cholecystitis according to severity were also 
discussed and modiﬁ  ed at the Meeting.T. Mayumi et al.: Results of the Tokyo Consensus Meeting  119
Table 4.  Severity assessment criteria for acute cholecystitis
(A) Proposed at International Meeting
“Severe (grade III)” acute cholecystitis
“Severe (grade III)” acute cholecystitis is associated with any one of the following categories. Organ/System dysfunction 
(Note: Thresholds were not discussed at the Summary session)
• Cardiovascular Hypotension
•  Neurologic (Disturbance of consciousness)
• Respiratory (PaO2/FiO2 ratio <300)
• Renal (Oliguria,  creatinine  >2.0 mg/dl)
• Hepatic (T.  bilirubin  >5.0 mg/dl)
• DIC (Platelets  <100 000/mm3)
Severe local inﬂ  ammation
Biliary peritonitis, pericholecystic abscess, hepatic abscess, gangrenous cholecystitis, emphysematous cholecystitis
“Moderate (grade II)” acute cholecystitis
“Moderate (grade II)” acute cholecystitis is associated with any of the following conditions.
• WBC  > 15 000, 18 000 (Threshold?)
• Palpable inﬂ  ammatory mass
• Onset  > 72–96 h
•    Serious thickening? (or “serious” deleted?), thickening of wall (include threshold?, if so, what thickness — 6–7 mm or 
8 mm? or twice normal gallbladder wall?) and ﬂ  uid collection around the gallbladder. (Is both thickness of gallbladder wall 
and ﬂ  uid collection around the gallbladder necessary?)
Liver cirrhosis should be described in a Note.
“Mild (grade I)” acute cholecystitis
“Mild (grade I)” acute cholecystitis does not meet the criteria of “severe” or “moderate” acute cholecystitis
(B) Final version of severity assessment criteria for acute cholecystitis
Mild (grade I) acute cholecystitis
“Mild (grade I)” acute cholecystitis does not meet the criteria of “severe (grade III)” or “moderate (grade II)” acute 
cholecystitis. It can also be deﬁ  ned as acute cholecystitis in a healthy patient with no organ dysfunction and mild 
inﬂ  ammatory changes in the gallbladder, making cholecystectomy a safe and low-risk operative procedure.
Moderate (grade II) acute cholecystitis
“Moderate” acute cholecystitis is associated with any one of the following conditions:
1.  Elevated WBC count (>18 000/mm3)
2.  Palpable tender mass in the right upper abdominal quadrant
3. Duration of  complaints  >72 ha
4.    Marked local inﬂ  ammation (biliary peritonitis, pericholecystic abscess, hepatic abscess, gangrenous cholecystitis, 
emphysematous cholecystitis)
a Laparoscopic surgery should be performed within 96 h of the onset of acute cholecystitis
Severe (grade III) acute cholecystitis
“Severe” acute cholecystitis is associated with dysfunction of any one of the following organs/systems
1.  Cardiovascular dysfunction (hypotension requiring treatment with dopamine 5 µg/kg per min, or any dose of dobutamine)
2.  Neurological dysfunction (decreased level of consciousness)
3. Respiratory dysfunction  (PaO2/FiO2 ratio <300)
4.  Renal dysfunction (oliguria, creatinine >2.0 mg/dl)
5. Hepatic dysfunction  (PT-INR  > 1.5)
6. Hematological dysfunction (platelet count <100 000/mm3)
Almost all panelists agreed with the ﬂ  owchart for 
“General guidance for the management of acute biliary 
infection” (Fig. 1). But in the ﬂ  owchart for the manage-
ment of acute cholangitis (Fig. 2a), panelists suggested 
that medical treatment should be begun before assess-
ment of the severity of acute cholangitis. Therefore, the 
ﬂ  owchart was changed, as shown in Fig. 2b.
In the ﬂ  owchart for the management of acute chole-
cystitis (Fig. 3a), because the concept of severity of 
cholecystitis was changed, this ﬂ  owchart was also modi-
ﬁ  ed (Fig. 3b). As “severe (grade III)” acute cholecystitis 
is associated with organ dysfunction, urgent/early drain-
age was preferred to urgent/early cholecystectomy for 
“severe (grade III)” cholecystitis. Similarly, as “moder-
ate (grade II)” acute cholecystitis is associated with 
difﬁ  culty to perform cholecystectomy due to local 
inﬂ  ammation, urgent/early drainage was preferred to 
early/elective cholecystectomy for “moderate (grade 
II)” cholecystitis also.
Deﬁ  nitions of severity: mild to severe (grades I–III)
Before the Meeting, the severity of both acute cholangi-
tis and acute cholecystitis was classiﬁ  ed as mild, Suspicion of acute biliary infection
Diagnostic criteria
Clinical presentations, blood test, 
diagnostic imaging
Acute cholangitis Acute cholecystitis
Other diseases
Differential 
diagnosis
Fig. 1.  Flowchart for general guidance 
for the management of acute biliary 
infection
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Fig. 2a,b.  Flowcharts for the manage-
ment of acute cholangitis. a  Original; 
b modiﬁ  ed at the Meeting
a
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moderate, and severe. But, with these criteria, even 
“moderate” acute cholangitis and “moderate” acute 
cholecystitis sometimes cause organ failure and even 
death. This deﬁ  nition could have confused users of these 
Guidelines, as “moderate” diseases are usually regarded 
as those having a good course without high morbidity or 
mortality. Therefore, instead of using the categories 
“mild”, “moderate”, and “severe”, the categories “grades 
I, II, and III” were used as the severity classiﬁ  cations for 
both acute cholangitis and acute cholecystitis.
Conclusion
In the preparation of the Guidelines for Acute Biliary 
Tract Infections (Acute Cholangitis and Cholecystitis), 
we found that there was not a sufﬁ  cient volume of high-
quality research. In this article, we have reported the 
process of developing the Guidelines, ranging from the 
identiﬁ  cation of current clinical practice for acute bili-
ary tract infection, to the proposals for the Guidelines 
and the improvements based on consensus. The Guide-
lines are the world’s ﬁ  rst international guidelines for the 
clinical management of acute biliary tract infections 
(acute cholangitis and cholecystitis), and it is strongly 
expected that they may be used broadly in everyday 
medical practice throughout the world as Guidelines 
that fully reﬂ  ect local and regional conditions.
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Fig. 3a,b.  Flowcharts for the manage-
ment of acute cholecystitis. a Original; b 
modiﬁ  ed at the Meeting. GB, gallbladder; 
LC, laparoscopic cholecystectomy b
a